Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer

Trial Profile

PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 14 Jan 2019

At a glance

  • Drugs 18F DCFPyL (Primary)
  • Indications Prostate cancer
  • Focus Biomarker; Diagnostic use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 06 Jul 2018 Planned End Date changed from 31 Jul 2019 to 31 Jul 2020.
    • 06 Jul 2018 Planned primary completion date changed from 31 Jul 2018 to 31 Jul 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top